On March 19th, at the MDA Clinical and Scientific Conference in Dallas, TX, Dr. Cornett will present exciting findings from the wearable sensor study conducted in collaboration with HNF’s partner, BioSensics. This innovative research highlights the potential of wearable technology to transform how disease progression and therapy effectiveness are measured for individuals with CMT.
Looking for new patients to participate in the BioSensics Wearable Study. Join us in Nashville, TN, April 24-26th.
CMT Summit + Retreat 2025: Uniting Patients, Researchers, Regulators, and Industry Leaders to...
CMT Simplified is here to make staying informed about Charcot-Marie-Tooth disease (CMT) easier...
NMD670, has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA)
Join the thousands of HNF volunteers who are fueling CMT research. The more you share, the more we’ll learn. Complete your GRIN surveys today!
1. Select and save your favorite images below 2. Post and tag us with your own personal message...
CMT Speak Out - #CMTspeakout Charcot-Marie-Tooth (CMT) disease is one of the most common yet...
HNF Awards the inaugural HNF Clinical Translation Fellowship in the amount of $170,000 to Kayla...
DAY #2 8:30am: Check-in & Breakfast 9:00 - 10:00am: Panel Discussion: Revolutionizing Clinical...
Dr. Pfeffer will offer complimentary in-person surgery consultations at our summit.
Join us for HNF 2024 CMT Clinical Trial Readiness Summit. To be held June 7&8th in San Diego, CA.
0 Comments